Back

An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Stem cells and cell therapy Stem cells and cell therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Carol Galvez-Monton

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)

14 More presentations in this session

Presentation thumbnail
iPS derived from human urine of Duchenne patients generate functionally competent cardiomyogenic cells: an in vitro cell model for functional studies and drug testing in heart failure.
Associate Professor D. D'Amario (Novara, IT)
Abstract
Presentation thumbnail
Improved therapeutic potential of adipose derived stem cell spheroid bodies
Presentation thumbnail
Exosome-mediated anti-aging effects of cardiosphere-derived cells.
Doctor L. Grigorian (Madrid, ES)
Abstract Slides
Presentation thumbnail
Isolation, characterization and partial direct differentiation of primary human cardiac and placental fibroblasts into induced cardiomyocytes iCM
Mr P. Sadeghi Pour (Bristol, GB)
Abstract Slides
Presentation thumbnail
Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction
Doctor C. Edlinger (Salzburg, AT)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Stem cells and cell therapy

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources